|
Information, Evidence, and Statistics for critical research appraisal
|
|
17
|
568
|
November 21, 2022
|
|
RCT with missing follow-up outcomes: ANCOVA + MI vs Mixed-Effects Modelling?
|
|
11
|
1470
|
November 3, 2022
|
|
Is it appropriate to present confidence intervals (CIs) for the outcome in each treatment group in the context of clinical trials?
|
|
5
|
323
|
November 2, 2022
|
|
Language for communicating frequentist results about treatment effects
|
|
196
|
95046
|
October 16, 2022
|
|
Background to PFS endpoint
|
|
19
|
4075
|
October 6, 2022
|
|
Quality of remdesivir trials
|
|
54
|
14771
|
October 5, 2022
|
|
Run-in phase in RCTs
|
|
10
|
5671
|
September 24, 2022
|
|
Individual response
|
|
172
|
21076
|
September 24, 2022
|
|
Cdisc in academia
|
|
1
|
437
|
September 7, 2022
|
|
Patient-specific treatment effects in RCTs: why should one present them?
|
|
1
|
1367
|
August 13, 2022
|
|
What is a fake measurement tool and how are they used in RCT
|
|
45
|
12733
|
August 3, 2022
|
|
Analyzing compositional outcome data
|
|
5
|
2311
|
July 28, 2022
|
|
Which to make as the primary analysis
|
|
1
|
1214
|
July 25, 2022
|
|
Non-inferiority and choice of scale (absolute vs relative)
|
|
4
|
1027
|
July 23, 2022
|
|
Evidence Based Decision Making and Meta-Analysis -- An Information Theoretic Critique
|
|
1
|
1755
|
June 10, 2022
|
|
Logistics of treatment effect estimation with interim analyses
|
|
1
|
809
|
June 1, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
2053
|
May 24, 2022
|
|
Summary Statistics vs Raw Data
|
|
8
|
6401
|
May 7, 2022
|
|
Methodology: Benefit Risk Assessment when Risk and Benefit are only observed in different timing
|
|
5
|
997
|
April 18, 2022
|
|
Covariate adjustment in non-inferiority trials
|
|
3
|
1670
|
April 14, 2022
|
|
RCT and "Mathematical Embellishment"
|
|
2
|
2186
|
April 5, 2022
|
|
Chi-Squared for relative risk
|
|
1
|
1369
|
March 27, 2022
|
|
Analysis of 2x2 trial with anticipated treatment interaction
|
|
9
|
2558
|
March 25, 2022
|
|
How to calculate number of events in each treatment arm given hazard ratio and CI?
|
|
2
|
1275
|
March 6, 2022
|
|
Covariate imbalance in RCT
|
|
5
|
2445
|
February 23, 2022
|
|
Estimate treatment effect in study with a composite complication score as outcome
|
|
9
|
1874
|
February 18, 2022
|
|
Single cluster cluster randomized crossover (CRXO) design?
|
|
3
|
1493
|
February 17, 2022
|
|
Bernoulli trials vs completely randomized trials
|
|
0
|
1358
|
January 5, 2022
|
|
Catastrophic Heterogeneity Meets "The Clairvoyant RCT"
|
|
0
|
1395
|
December 28, 2021
|
|
Cost-effectiveness based interim analysis
|
|
2
|
1843
|
December 15, 2021
|